Circulating and intrahepatic antiviral B cells are defective in hepatitis B.
Saved in:
| Title: | Circulating and intrahepatic antiviral B cells are defective in hepatitis B. |
|---|---|
| Authors: | Burton AR; Division of Infection and Immunity, Institute of Immunity and Transplantation, and., Pallett LJ; Division of Infection and Immunity, Institute of Immunity and Transplantation, and., McCoy LE; Division of Infection and Immunity, Institute of Immunity and Transplantation, and., Suveizdyte K; Division of Infection and Immunity, Institute of Immunity and Transplantation, and., Amin OE; Division of Infection and Immunity, Institute of Immunity and Transplantation, and., Swadling L; Division of Infection and Immunity, Institute of Immunity and Transplantation, and., Alberts E; Division of Infection and Immunity, Institute of Immunity and Transplantation, and., Davidson BR; Department of Surgery, University College London, London, United Kingdom., Kennedy PT; Centre for Immunobiology, Barts and the London, London, United Kingdom., Gill US; Centre for Immunobiology, Barts and the London, London, United Kingdom., Mauri C; Division of Medicine, University College London, London, United Kingdom., Blair PA; Division of Medicine, University College London, London, United Kingdom., Pelletier N; Roche Innovation Center, Basel, Switzerland., Maini MK; Division of Infection and Immunity, Institute of Immunity and Transplantation, and. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2018 Oct 01; Vol. 128 (10), pp. 4588-4603. Date of Electronic Publication: 2018 Aug 09. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
